Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2719 results

Sort By:

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Study ID: NCT06904066
Start Date: 2025-11-06
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

86

Intervention / Treatment

far away

cyclophosphamide

fludarabine phosphate

Individual Patient TCR-Transduced PBL

TruSight Oncology (TSO) 500

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Hypoxic Red Blood Cells in Sickle Cell Anemia

Study ID: NCT06743113
Start Date: 2026-01
End Date: 2028-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

48

Intervention / Treatment

Hemanext ONE System

Conventional RBCs

Sponsor

Hemanext

Source: clinicaltrials.gov

Share:
Add to list

A Trauma-Informed Intervention for the Newly HIV-Diagnosed

Study ID: NCT07055360
Start Date: 2026-01-05
End Date: 2026-09-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Resilience-Based Intervention for Stress Reduction and HIV-Related Efficacy (RISE)

Waitlist control: Text messaging-reminder comparison condition

Sponsor

Temple University

Source: clinicaltrials.gov

Share:
Add to list

Impact of Home Non Invasive Ventilation in Patients With Chronic Obstructive Pulmonary Disease Discharged From Assiut University Hospital

Study ID: NCT07198880
Start Date: 2026-01-01
End Date: 2028-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

BiPAP device (non invasive ventilation)

Optimal Medical Management ( long acting beta agonist , long acting muscarinic antagonist and inhaled corticosteroids)

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Umbilical Venous Versus Peripherally Inserted Central Catheters in Neonates: A Prospective Cohort Study of Complications, Catheter Survival, and CLABSI"

Study ID: NCT07209670
Start Date: 2025-12-01
End Date: 2028-12-20
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

360

Intervention / Treatment

peripherally inserted central catheter insertion

umbilical venous catheters insertion

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Symplicity China Study

Study ID: NCT07081243
Start Date: 2025-11-04
End Date: 2031-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Symplicity Spyral Renal Denervation System

Sponsor

Medtronic Vascular

Source: clinicaltrials.gov

Share:
Add to list

SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules

Study ID: NCT06775587
Start Date: 2026-04-08
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Serum Raman spectroscopy intelligent diagnostic system

Sponsor

Fuzhou General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

Study ID: NCT06274749
Start Date: 2025-11-06
End Date: 2027-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Urolithin A

Placebo

Sponsor

National Institute on Aging (NIA)

Source: clinicaltrials.gov

Share:
Add to list

Chinese Real-world Study of Treatment of Vestibular Migraine

Study ID: NCT07203248
Start Date: 2025-12
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

CGRP R Inhibitor; CGRP Inhibitor

none-CGRP

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Source: clinicaltrials.gov

Share:
Add to list

Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

Study ID: NCT07160686
Start Date: 2026-03-02
End Date: 2030-03-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1456

Intervention / Treatment

Apixaban

Placebo

Sponsor

University of Birmingham

Source: clinicaltrials.gov

Share:
Add to list